![Matthew Hawryluk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Hawryluk
Directeur/Membre du Conseil chez
PRECISION THERAPEUTICS INC
Fortune : 81 737 $ au 31/05/2026
Profil
Matthew J.
Hawryluk is currently Independent Director at Axe Compute, Inc. since 2022, Director at Ourotech, Inc., and Chief Business Officer at Prime Medicine, Inc. starting in 2025.
Formerly, Dr. Hawryluk was Vice President-Corporate & Business Development at Foundation Medicine, Inc. and Chief Business Officer & Executive Vice President at Gritstone bio, Inc. from 2015 to 2024.
Education includes undergraduate studies at the University of Notre Dame, an MBA from Tepper School of Business, and a doctorate from the University of Pittsburgh School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AXE COMPUTE INC. 0,35 % | 20/04/2026 | 11 727 ( 0,35 % ) | 81 737 $ | 31/05/2026 |
Postes actifs de Matthew Hawryluk
| Sociétés | Poste | Début |
|---|---|---|
| PRECISION THERAPEUTICS INC | Directeur/Membre du Conseil | 29/11/2022 |
| PRIME MEDICINE, INC. | Corporate Officer/Principal | 03/11/2025 |
Ourotech, Inc.
 Ourotech, Inc. Medical SpecialtiesHealth Technology Manufactures cancer treatment devices | Directeur/Membre du Conseil | - |
Anciens postes connus de Matthew Hawryluk
| Sociétés | Poste | Fin |
|---|---|---|
| GRITSTONE BIO, INC. | Corporate Officer/Principal | 31/12/2024 |
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | - |
Formation de Matthew Hawryluk
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Predictive Oncology, Inc.
 Predictive Oncology, Inc. Medical SpecialtiesHealth Technology Operates as a development stage company manufacturing an environmentally conscientious system for the collection and disposal of infectious fluids | Health Technology |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Tepper School of Business
 Tepper School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pittsburgh School of Medicine
 University of Pittsburgh School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
Ourotech, Inc.
Ourotech, Inc. Medical SpecialtiesHealth Technology Manufactures cancer treatment devices | Health Technology |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
